Abstract: Embodiments describe a medicant prescribing system, where the prescribing of the medicant is carried out on to a smart card, and where the prescribing is a suggestion without complete specificity of the medicant or its quantities. The card is used to obtain the medicant, and to monitor types and quantities of the medicant both and the quantities of the medicant. An embodiment requires using the card to obtain the medicant, since the prescription has been placed on or otherwise associated with the card. Another aspect requires monitoring the medicant card to monitor the actions at multiple different medicant sources, while using information on the card to pay for the medicant. One aspect forces patients to use the card in order to purchase. An embodiment uses intelligence in the card to allow the card to be used offline, but synchronize with a database. An embodiment enforces synchronization at specified intervals.

Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.

Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.

Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia.

Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor ? agonists for treating Estrogen Receptor ? mediated diseases such as benign prostatic hyperplasia.

Abstract: The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor ? agonists. Such agonists are useful for the treating Estrogen Receptor ? mediated diseases such as prostate cancer or BPH.